Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Ulus Travma Acil Cerrahi Derg ; 19(1): 83-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23588988

ABSTRACT

Duplication of the vermiform appendix is a rare congenital abnormality and usually found incidentally during laparotomy. The Modified Cave-Wallbridge classification is used to describe the location of the appendixes in relation to each other and to the cecum as well as the extent of the duplication. We report a 45-year-old patient who underwent laparotomy for acute abdominal pain. The operative finding was double acute appendicitis in appendical duplication. The appendixes were removed separately, as it was type B duplication. Since appendectomy is the most common abdominal operation, all surgeons should keep this rare clinical entity in mind.


Subject(s)
Appendicitis/diagnosis , Appendix/abnormalities , Abdominal Pain/etiology , Appendectomy , Appendicitis/surgery , Appendix/surgery , Humans , Male , Middle Aged
2.
Acta Histochem ; 115(1): 32-41, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22494612

ABSTRACT

Autologous/allogenic skin grafts constituted from differentiated adult or embryonic stem cells can be used in treatment of skin disorders. In our study we aimed to differentiate keratinocytes from mouse embryonic stem cells and the transfer of viable keratinocyte-like cells to a model of surgical skin wound of mouse. Embryoid bodies, derived from mouse embryonic stem cells, were cultured on basement membrane matrix with added BMP-4 for 10 days. The identification of differentiated keratinocyte-like cells was done by detection of cytokeratin-8 and cytokeratin-14 localization using an indirect immunoperoxidase technique and transmission electron microscopy evaluation. Distribution of BrdU, cytokeratin-8 and cytokeratin-14 were evaluated using an indirect immunoperoxidase technique from the experimental (dressing including BrdU labelled cells applied after the surgical wound was created on mouse), control (only the surgical wound was created on mouse) and sham (only the dressing applied after the surgical wound was created on mouse) in groups after 3, 5 and 7 days. Immunohistochemically and ultrastructurally, cells derived from mouse embryonic stem cells were similar to differentiated keratinocyte-like cells. Differentiated keratinocyte-like cells were demonstrated by positive BrdU, cytokeratin-8 and cytokeratin-14 staining after transfer to the wound area. In the experimental group wound healing was better after transferring differentiated keratinocytes when compared to the sham and control groups. In vivo continuity and usability of derived cells are very important issues. In wound repair mechanisms, keratinocyte-like cells could provide positive effects during the wound healing and could be used in clinical treatments of wound repair process.


Subject(s)
Dermatologic Surgical Procedures , Embryonic Stem Cells/cytology , Keratinocytes/cytology , Keratinocytes/transplantation , Wound Healing , Animals , Cell Differentiation , Male , Mice , Mice, Inbred BALB C
3.
Indian J Pathol Microbiol ; 54(4): 800-2, 2011.
Article in English | MEDLINE | ID: mdl-22234115

ABSTRACT

The diagnosis of synchronous prostatic and rectal carcinomas is uncommon. To make a correct diagnosis, biopsies of both sites are mandatory. Pathological slides should be compared and immunohistochemical staining should be taken into consideration. In this paper, an unexpected case of synchronous rectal and prostatic carcinomas arising in an 84-year-old male with hematemesis and pelvic pain is reported. These two tumoral components have a distinctive histological appearance. Immunohistochemical evaluation confirmed the diagnosis of these synchronous tumors. This case emphasizes that rectal and prostatic carcinomas can arise simultaneously. In this situation, providing clinicopathological correlation and deciding the necessity of intraoperative consultation in proper time are extremely important.


Subject(s)
Carcinoma/diagnosis , Carcinoma/pathology , Prostatic Neoplasms/complications , Prostatic Neoplasms/diagnosis , Rectal Neoplasms/complications , Rectal Neoplasms/diagnosis , Aged, 80 and over , Biopsy , Histocytochemistry , Humans , Immunohistochemistry , Male , Microscopy , Prostatic Neoplasms/pathology , Rectal Neoplasms/pathology
4.
Ulus Travma Acil Cerrahi Derg ; 16(4): 293-9, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20849043

ABSTRACT

BACKGROUND: This prospective, controlled experimental study was planned to investigate the effects of levosimendan on transforming growth factor (TGF)-beta3 and Smad1, Smad2 and Smad3 expression in the early stages of sepsis. METHODS: Twenty-four rats were randomized into four groups: (1) sham-operated controls, (2) dobutamine group--subjected to abdominal hypertension and peritonitis-induced sepsis using cecal ligation and puncture (CLP), then treated with 10 microg x kg(-1) min(-1) intravenous (IV) dobutamine infusion, (3) levosimendan group--as in 2, then treated with levosimendan IV bolus 200 microg x kg(-1) followed by 200 microg x kq(-1) min(-1) IV infusion, and (4) a control group as in 2, with no treatment. All rats were killed 8 hours after CLP. Aorta tissue samples were analyzed by immunohistochemical staining. RESULTS: CLP caused mild interleukin (IL)-1 immunostaining in both control and dobutamine groups. Immunoreactivity of tumor necrosis factor (TNF)-alpha was mild in both sham and control groups. TGF-beta3 immunostaining was mildly increased in groups sham, control and dobutamine, whereas it was found moderate in group levosimendan. Smad1, Smad2 and Smad3 were found moderately increased only in group levosimendan. CONCLUSION: Beneficial effects of levosimendan on hemodynamics and global oxygen transport were reported in experimental and clinical trials. Besides its potency on C++ ion sensitivity, it should influence inflammatory cytokine production by diminishing TGF-beta3 and Smad1, Smad2 and Smad3 expression.


Subject(s)
Aorta/physiology , Hydrazones/pharmacology , Pyridazines/pharmacology , Sepsis/physiopathology , Transforming Growth Factor beta3/physiology , Animals , Aorta/drug effects , Aorta/physiopathology , Blood Pressure/drug effects , Dopamine/pharmacology , Male , Rats , Rats, Wistar , Sepsis/genetics , Simendan , Smad1 Protein/drug effects , Smad1 Protein/genetics , Smad2 Protein/drug effects , Smad2 Protein/genetics , Smad3 Protein/drug effects , Smad3 Protein/genetics , Transforming Growth Factor beta3/drug effects , Transforming Growth Factor beta3/genetics , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/genetics , Vasodilator Agents/pharmacology
5.
Acta Histochem ; 111(5): 404-14, 2009.
Article in English | MEDLINE | ID: mdl-19027145

ABSTRACT

The effects of levosimendan on acute lung injury induced by peritonitis and abdominal hypertension in the early stages of sepsis in rats were investigated. Twenty-four adult male Wistar rats were randomized into: (1) sham, (2) subjected to abdominal hypertension and peritonitis induced lung injury using cecal ligation and puncture, then treated by dobutamine, (3) subjected to abdominal hypertension and peritonitis induced lung injury using cecal ligation and puncture, then treated by levosimendan, and (4) controls subjected to abdominal hypertension and peritonitis induced lung injury using cecal ligation and puncture with no treatment. In the control and levosimendan groups, cecal ligation and puncture resulted in moderate IL-1beta immunolabelling in lung tissue; marked IL-1beta immunolabelling was demonstrated in the dobutamine group. TNF-alpha immunolabelling was negative in both the sham and levosimendan groups, but moderate and weak immunoreactivities were observed in the dobutamine and control groups, respectively. There were almost no TUNEL positive cells in the sham, but they were prominent in the control. TUNEL positive cells were significantly less in the levosimendan treated lungs when compared to control and dobutamine groups. Immunoreactivity of eNOS was stronger in the dobutamine group when compared with the levosimendan group. In addition, iNOS immunoreactivity was strongly detected in the control group; this immunoreactivity was less in the levosimendan group than the dobutamine group. In this experimental sepsis model, treatment with levosimendan had a marked effect on attenuating or decreasing apoptosis and inflammation in the lung.


Subject(s)
Cardiotonic Agents/pharmacology , Dobutamine/pharmacology , Hydrazones/pharmacology , Pyridazines/pharmacology , Acute Lung Injury/etiology , Acute Lung Injury/metabolism , Animals , Hypertension/physiopathology , Immunohistochemistry , In Situ Nick-End Labeling , Interleukin-1beta/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Male , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide Synthase Type III/metabolism , Rats , Rats, Wistar , Simendan , Tumor Necrosis Factor-alpha/metabolism
6.
Acta Histochem ; 111(1): 74-82, 2009.
Article in English | MEDLINE | ID: mdl-18554688

ABSTRACT

To clarify the effects of long-term ocreotide (a long-acting somatostatin analogue) treatment on mucosal changes in a rat model of portal hypertensive enteropathy, groups of male Swiss albino rats (n=15 each) were randomly assigned to one of three treatment arms. These were: sham laparotomy+twice daily subcutaneous saline 0.5 mL (Group 1); portal hypertension induction+twice daily subcutaneous saline 0.5 mL (Group 2); and portal hypertension induction+subcutaneous ocreotide 100 microg/kg/12h (Group 3). After 12 weeks of treatment, jejunal and ileal tissue specimens were obtained and evaluated histopathologically (villus/crypt ratio, mean diameter of dilated vessels, mucosal edema, and fibromuscular proliferation in the lamina propria) and immunohistochemically (vascular endothelial growth factor (VEGF), von Willebrand factor (F8), and cluster of differentiation 34 (CD34) labelling). In jejunal specimens, the villus/crypt ratio was markedly lower in Group 2 (2.38+/-0.46 microm) than in Group 1 (5.07+/-2.25 microm) or Group 3 (4.97+/-2.19 microm); mean diameter of dilated vessels was markedly higher in Group 2 (43.30+/-5.71 microm) than in Group 1 (33.53+/-4.00 microm) or Group 3 (36.76+/-3.96 microm); mucosal edema and fibromuscular proliferation were universally absent in Group 1 when compared with the other groups. There were statistically significant differences (p<0.05) between Groups 1 and 2 for villus/crypt ratio, mean diameter of dilated vessels, VEGF immunolabelling intensity, and CD34 immunolabelling intensity; between Groups 1 and 3 for mean diameter of dilated vessels, VEGF immunolabelling intensity, and CD34 immunolabelling intensity; and between Groups 2 and 3 for villus/crypt ratio, mean diameter of dilated vessels, and VEGF immunolabelling intensity. In ileal tissue specimens, the villus/crypt ratio was markedly lower in Group 2 (5.51+/-0.67 microm) than in either Group 1 (7.19+/-2.18 microm) or Group 3 (7.62+/-2.58 microm); mean diameter of dilated vessels was markedly higher in Group 2 (46.36+/-4.77 microm) than in either Group 1 (36.43+/-4.57 microm) or Group 3 (41.31+/-4.70 microm); while mucosal edema was absent in Group 1, it was present in Group 2 and Group 3; and fibromuscular proliferation was universally absent. There were statistically significant differences (p<0.05) between Groups 1 and 2 for villus/crypt ratio and mean diameter of dilated vessels; between Groups 1 and 3 for mean diameter of dilated vessels; and between Groups 2 and 3 for villus/crypt ratio, mean diameter of dilated vessels, and VEGF immunolabelling intensity. Together, these findings indicate that ocreotide treatment ameliorates histomorphological changes in a rat model of portal hypertensive enteropathy.


Subject(s)
Hypertension, Portal/drug therapy , Intestinal Mucosa/drug effects , Octreotide/pharmacology , Octreotide/therapeutic use , Animals , Disease Models, Animal , Gastrointestinal Agents/administration & dosage , Gastrointestinal Agents/pharmacology , Gastrointestinal Agents/therapeutic use , Hypertension, Portal/pathology , Immunohistochemistry , Injections, Subcutaneous , Intestinal Mucosa/chemistry , Intestinal Mucosa/pathology , Male , Octreotide/administration & dosage , Rats , Vascular Endothelial Growth Factor A/analysis
7.
Can J Surg ; 51(5): 383-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18841221

ABSTRACT

BACKGROUND: Hernia repair is one of the most common surgical procedures, and some patients suffer from chronic pain after hernia surgery. The aim of the present study was to evaluate chronic postherniorrhaphy pain in men who underwent Lichtenstein mesh repair or preperitoneal (posterior) repair. METHODS: Our study included 94 male inpatients. Two surgeons experienced in both Lichtenstein and preperitoneal hernia repair performed the procedures. We controlled postoperative pain with systemic analgesic therapy. We evaluated the patients over the subsequent 12 months, using a questionnaire to focus on chronic pain and its limitations to their quality of life. RESULTS: The overall incidence of chronic pain at 2 months was 5%. About 6% of patients who underwent Lichtenstein repair (n = 70) and 4% of patients who underwent preperitoneal repair (n = 24) experienced chronic pain. All patients with chronic pain rated their pain as slight or moderate. Their pain was present occasionally and was related to physical stress. None of the patients were unable to work. After 12 months of follow-up, the overall incidence of chronic pain decreased to 3%, with 3 patients in Lichtenstein group reporting chronic pain with slight limitations in sports and social activities. CONCLUSION: The incidence rates of chronic pain after Lichtenstein and preperitoneal repair were 6% and 4%, respectively. Inpatient status might have resulted in low incidences with both approaches.


Subject(s)
Hernia, Inguinal/surgery , Pain, Postoperative/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Chronic Disease , Humans , Incidence , Male , Middle Aged , Quality of Life , Surgical Mesh
8.
Surg Endosc ; 22(6): 1487-92, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18027038

ABSTRACT

BACKGROUND: Laparoscopic cholecystectomies are associated with an appreciably high rate of postoperative nausea and vomiting (PONV). This study was designed to compare the effectiveness of ondansetron, granisetron, and dexamethasone for the prevention of PONV in patients after laparoscopic cholecystectomy. METHODS: A total of 80 American Society of Anesthesiologists (ASA) physical class I-II patients scheduled for laparoscopic cholecystectomy were included in this randomized, double blind, placebo-controlled study. All patients received a similar standardized anesthesia and operative treatment. Patients were randomly divided into four groups (n = 20 each). Group 1, consisting of control patients, received 0.9% NaCl; group 2 patients received ondansetron 4 mg i.v.; group 3 patients received granisetron 3 mg i.v.; and group 4 patients received dexamethasone 8 mg i.v., all before the induction of anesthesia. Both nausea and vomiting were assessed during the first 24 h after the procedure. RESULTS: The total incidence of PONV was 75% with placebo, 35% with ondansetron, 30% with granisetron, and 25% with dexamethasone. The incidence of PONV was significantly less frequent in groups receiving antiemetics (p < 0.05). The differences between dexamethasone, granisetron, and ondansetron were not significant. CONCLUSIONS: Prophylactic dexamethasone 8 mg i.v. significantly reduced the incidence of PONV in patients undergoing laparoscopic cholecystectomy. Dexamethasone 8 mg was as effective as ondansetron 4 mg and granisetron 3 mg, and it was more effective than placebo.


Subject(s)
Antiemetics/therapeutic use , Cholecystectomy, Laparoscopic/methods , Dexamethasone/therapeutic use , Granisetron/therapeutic use , Ondansetron/therapeutic use , Postoperative Nausea and Vomiting/prevention & control , Preoperative Care/methods , Adult , Aged , Antiemetics/administration & dosage , Dexamethasone/administration & dosage , Dose-Response Relationship, Drug , Double-Blind Method , Female , Follow-Up Studies , Gallbladder Diseases/surgery , Granisetron/administration & dosage , Humans , Incidence , Injections, Intravenous , Male , Middle Aged , Ondansetron/administration & dosage , Postoperative Nausea and Vomiting/epidemiology , Treatment Outcome , United States/epidemiology
9.
Ulus Travma Acil Cerrahi Derg ; 13(4): 316-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17978915

ABSTRACT

We report a case with a late diagnosis of posttraumatic lateral abdominal wall hematoma. The patient was admitted with a giant hematoma presenting with pleural effusion, anemia and weight loss on postoperative 30th day after a blunt trauma. Computerized tomography analysis revealed a hematoma extending from axilla to the gluteus. Fine-needle aspiration revealed an exudative fluid and five liters of fluid collection was drained. Misdiagnosed lateral abdominal wall hematomas can be diagnosed with nonspecific findings as in this case.


Subject(s)
Abdominal Injuries/diagnosis , Hematoma/diagnosis , Abdominal Injuries/complications , Abdominal Injuries/diagnostic imaging , Abdominal Injuries/surgery , Accidents, Traffic , Adolescent , Anemia/etiology , Biopsy, Fine-Needle , Diagnosis, Differential , Fever/etiology , Hematoma/complications , Hematoma/diagnostic imaging , Hematoma/surgery , Humans , Male , Tomography, X-Ray Computed
10.
J Trauma ; 62(4): 880-5, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17426542

ABSTRACT

BACKGROUND: To study whether enteral pretreatment with a synbiotic composition of lactic acid bacteria and bioactive fibers can reduce peritonitis-induced lung neutrophil infiltration and tissue injury in rats. MATERIALS AND METHODS: Rats were divided into five groups, and subjected to induction of peritonitis-induced lung injury using a cecal ligation and puncture model (CLP). All animals were pretreated for 3 weeks prior the CLP by daily gavage with either (1) a synbiotic composition (10(10) CFU of Pediococcus pentosaceus 5-33:3, 10(10) CFU of Leuconostoc mesenteroides 77:1, 10(10) CFU of L. paracasei subspecies paracasei, 10(10) CFU of L. plantarum 2362 plus fermentable fibers), (2) fermentable fibers alone, (3) nonfermentable fibers, (4) a probiotic composition (10(10) CFU of P. pentosaceus 5-33:3, 10(10) CFU of L. mesenteroides 77:1, 10(10) CFU of L. paracasei subsp. paracasei, 10(10) CFU of L. plantarum 2,362), or (5) a heat-killed probiotic composition. All animals were killed 24 hours after CLP and lung tissue samples were studied for degree of neutrophil infiltration and levels of tumor necrosis factor (TNF)-alpha, Interleukin (IL)-1beta. In addition the lung wet-to-dry tissue weight ratio, the myeloperoxidase activity, and malondialdehyde content were also assessed. RESULTS: No mortality was encountered in any of the groups. Histologic signs of lung injury (number of neutrophils and TNF-alpha, IL-1beta staining) were observed in all groups except the synbiotic and probiotic treated groups. Myeloperoxidase activity and malondialdehyde content were significantly lower in the two lactobacillus- pretreated groups, with no difference between them. Heavy infiltration of lung tissue with neutrophils was observed only in fiber-treated (302.20 +/- 7.92) and placebo-treated (266.90 +/- 8.92) animals. This was totally abolished in the synbiotic-treated group (34.40 +/- 2.49). Lung edema (wet-to-dry lung weight ratio) was significantly reduced in the synbiotic-treated group (4.92 +/- 0.13 vs. 5.07 +/- 0.08 and 5.39 +/- 0.10, respectively). CONCLUSION: Three weeks of preoperative enteral administration of a synbiotic composition reduced peritonitis-induced acute lung injury in rats in a CLP model.


Subject(s)
Leuconostoc , Pediococcus , Peritonitis/complications , Probiotics/therapeutic use , Respiratory Distress Syndrome/prevention & control , Sepsis/complications , Administration, Oral , Animals , Interleukin-1beta/metabolism , Lung/immunology , Lung/metabolism , Lung/pathology , Male , Malondialdehyde/metabolism , Neutrophils/physiology , Peritonitis/metabolism , Peroxidase/metabolism , Premedication , Rats , Rats, Wistar , Respiratory Distress Syndrome/etiology , Tumor Necrosis Factor-alpha/metabolism
11.
World J Surg ; 30(6): 1000-6, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16736328

ABSTRACT

BACKGROUND: The effects of portal vein occlusion on the pancreas are not clearly understood. Therefore, we studied histomorphological changes induced in the rat pancreas by various periods of portal vein occlusion. MATERIALS AND METHODS: Sixty female Wistar albino rats were randomly allocated into four groups of 15 each. In Group I (control), rats underwent sham laparotomy to expose the portal vein proximal to its bifurcation. In Groups II-IV, rats underwent laparotomy followed by portal vein occlusion by clamping for 15, 30, and 60 minutes respectively. The pancreas was removed immediately after sham laparotomy in Group I and immediately after clamp release in Groups II-IV. Pancreatic tissue specimens were subjected to histochemical analysis for cell typing and diagnosis, immunohistochemical analysis for identification of the inflammatory markers tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), endothelial nitric oxide synthase (eNOS), and inducible NOS (iNOS), and TUNEL analysis was carried out for identification of apoptotic cells. RESULTS: Histochemistry revealed signs of inflammation in pancreatic tissue from rats subjected to portal vein occlusion. Immunohistochemistry revealed that the expression of proinflammatory cytokines TNF-alpha and IL-1beta and the oxidative damage indicator iNOS in rat pancreatic tissue increased progressively with the duration of portal vein occlusion. TUNEL assay revealed no signs of apoptosis in any of the groups. CONCLUSION: We conclude that portal vein occlusion triggers an inflammatory response in the pancreas that worsens the longer the occlusion lasts.


Subject(s)
Pancreas/pathology , Pancreatitis/physiopathology , Portal Vein/pathology , Animals , Apoptosis , Constriction, Pathologic/physiopathology , Female , Immunohistochemistry , In Situ Nick-End Labeling , Interleukin-1beta/analysis , Nitric Oxide Synthase Type II/analysis , Nitric Oxide Synthase Type III/analysis , Pancreas/metabolism , Pancreatitis/metabolism , Pancreatitis/pathology , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/analysis
12.
Tuberk Toraks ; 53(2): 181-4, 2005.
Article in English | MEDLINE | ID: mdl-16100657

ABSTRACT

Though the high incidence of pancreatic metastasis of lung cancer has been reported in autopsy series, symptomatic cases with jaundice due to that is very rare. Dominant histological type with pancreatic metastases is small cell carcinoma and prognosis is poor. Hereby, we report a case initially presenting with gastroenterologic symptoms as jaundice, nausea, vomiting, weight loss and abdominal pain and then diagnosed as primary small cell carcinoma of the lung with metastasis to pancreas. He underwent a palliative surgery due to obstructive jaundice. This presented case is a rare one with its priority of gastroenterologic symptoms rather than pulmonary complaints.


Subject(s)
Carcinoma, Small Cell/diagnosis , Lung Neoplasms/diagnosis , Pancreatic Neoplasms/diagnosis , Carcinoma, Small Cell/complications , Carcinoma, Small Cell/diagnostic imaging , Carcinoma, Small Cell/secondary , Diagnosis, Differential , Fatal Outcome , Humans , Jaundice/etiology , Lung Neoplasms/complications , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Male , Middle Aged , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/secondary , Tomography, X-Ray Computed
13.
Cell Biochem Funct ; 23(3): 213-20, 2005.
Article in English | MEDLINE | ID: mdl-15378524

ABSTRACT

Polypropylene mesh is the most widely used material in inguinal hernia repair. Although polypropylene mesh is known as an inert material, it is experimentally proven that mesh generates a chronic inflammatory tissue reaction. The aim of the present study was to investigate the long-term effects of polypropylene mesh material used in inguinal hernia operations on testicular function, testicular nitric oxide (NO) metabolism and germ cell-specific apoptosis in rats. The study comprised 40 male rats that were randomly allocated into two groups. In group 1, the left spermatic cord was elevated and a 0.5 x 1 cm polypropylene mesh was placed behind the left inguinal spermatic cord and group 2 consisted of the sham-operated controls. Blood samples were taken at 6 months preoperatively and postoperatively after to assess luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels for hormonal evaluation. Testicular NO was evaluated by the Griess method, apoptosis by a TUNEL method and inducible nitric oxide synthase (iNOS) and endothelial NOS (eNOS) expressions by immunohistochemical staining. Mild (+) eNOS expression was observed in all specimens. Mild (+) iNOS expression was only detected in ipsilateral testis of the mesh-implanted study group. Apoptotic cells were not detected in any samples. We are of the opinion that long-term polypropylene mesh implantation has no effect on testicular hormonal function and only a limited effect on nitric oxide levels and this effect is not sufficient to cause apoptosis in testis that could lead to infertility. It seems that mesh implantation is a reliable method in inguinal hernia repair; however, further work is required by more sensitive methods to fully elucidate the potential testicular damage.


Subject(s)
Hernia, Inguinal/surgery , Nitric Oxide/metabolism , Prostheses and Implants , Surgical Mesh , Testis/metabolism , Animals , Apoptosis , Infertility, Male/etiology , Ischemia/metabolism , Ischemia/pathology , Male , Postoperative Complications/metabolism , Postoperative Complications/pathology , Rats , Rats, Inbred Strains , Spermatogenesis , Testis/pathology
14.
Acta Gastroenterol Belg ; 66(3): 255-7, 2003.
Article in English | MEDLINE | ID: mdl-14618960

ABSTRACT

AIMS: Curative therapy of alveolar echinococcosis is total surgical removal of the infected tissue and concomitant chemotherapy. However, this curative resection can be done on a limited number of patients, for the remaining ones various palliative procedures can be performed. METHOD: In this article it is aimed to present the result of long-term albendazole treatment in patient who had a palliative hepatojejunostomy for obstructive jaundice due to unresectable alveolar echinococcosis. RESULTS: Systemic albendazole treatment was initiated in this patient after palliative hepatojejunostomy procedure. During follow up there was no abnormality in blood chemistry and a considerable regression in size of the lesion was found in postoperative month 24. Residual hepatic lesion was histopathologically documented and showed apparently non-viable parasitic cysts by biopsy. These findings suggest the long-term albendazole therapy being parasitocidal. CONCLUSIONS: Palliative or mass reduction surgery combined with long-term albendazole therapy is the standard therapy for advanced disease, especially when curative resection might result in significant morbidity and mortality.


Subject(s)
Albendazole/therapeutic use , Anthelmintics/therapeutic use , Echinococcosis, Hepatic/drug therapy , Adult , Digestive System Surgical Procedures/methods , Echinococcosis, Hepatic/diagnostic imaging , Echinococcosis, Hepatic/surgery , Female , Follow-Up Studies , Humans , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
15.
Hepatogastroenterology ; 50(53): 1352-5, 2003.
Article in English | MEDLINE | ID: mdl-14571736

ABSTRACT

BACKGROUND/AIMS: The aim of the study is to clarify the effects of octreotide and propranolol, agents used in the treatment of portal hypertension, on mucosal changes in portal hypertensive colopathy. METHODOLOGY: Portal hypertension was induced in all rats by partial portal vein ligation, and after the operation all rats were caged for a 10-week period. Then, animals were divided into three groups and for two weeks medical treatment were administered to the individual groups as follows: Control group, saline 0.5 mL/day, intraperitoneally. Octreotide group, octreotide 100 micrograms/kg/12 hours, subcutaneously. Propranolol group, propranolol 20 mg/kg/day, intraperitoneally. In order to assess the portal hypertensive colopathy, criteria such as mean diameters of dilated vessels in colonic mucosa, and the existence of mucosal edema, capillary ectasia, hyperemia and hemorrhage, inflammation were used. RESULTS: When parameters were compared for the control versus propranolol groups, mucosal edema and hyperemia and hemorrhage criteria were found to be significant for the propranolol group; control versus octreotide groups, mucosal edema, capillary ectasia, and hyperemia and hemorrhage criteria were found to be significant for the octreotide group; octreotide versus propranolol groups, capillary ectasia and mucosal edema criteria were found to be significant for the octreotide group. CONCLUSIONS: The mucosal changes in portal hypertensive colopathy could be corrected by drugs modifying portal blood flow, octreotide may find a place in the treatment of portal hypertensive colopathy.


Subject(s)
Antihypertensive Agents/pharmacology , Gastrointestinal Agents/pharmacology , Hypertension, Portal/pathology , Intestinal Mucosa/drug effects , Octreotide/pharmacology , Propranolol/pharmacology , Animals , Intestinal Mucosa/pathology , Male , Portal System/drug effects , Rats , Rats, Inbred Strains , Regional Blood Flow/drug effects
16.
Dig Surg ; 20(1): 69-71, 2003.
Article in English | MEDLINE | ID: mdl-12637812

ABSTRACT

BACKGROUND: Chronic anal fistulas are not rare conditions, however, the development of a carcinoma in a long-standing fistula-in-ano is rare. METHODS: The case of a 77-year-old male with a large perianal mucinous adenocarcinoma arising in a long-standing fistula-in-ano is presented. RESULTS: Perianal biopsy revealed mucinous adenocarcinoma. Abdominal CT, double contrast barium examination and flexible sigmoidoscopy revealed no other tumoral lesion in the colon and rectum. CONCLUSION: The patient underwent abdominoperineal resection including wide tumor excision on the gluteal region. The final reconstruction was performed by bilateral gracilis musculocutaneous flaps. Due to clinical and histopathological evidence it was thought that a curative resection had been performed. To date he is clinically disease free.


Subject(s)
Adenocarcinoma, Mucinous/etiology , Rectal Fistula/complications , Rectal Neoplasms/etiology , Adenocarcinoma, Mucinous/surgery , Aged , Chronic Disease , Fissure in Ano/complications , Humans , Male , Rectal Neoplasms/surgery
17.
Breast J ; 8(1): 38-44, 2002.
Article in English | MEDLINE | ID: mdl-11856160

ABSTRACT

We have reviewed the histopathological, clinical outcome and immunohistochemical status in 21 women with cystosarcoma phyllodes (CSP) tumors of the breast. We assessed 12 tumors as histopathologically benign and 9 tumors as malignant. The median patient ages in benign and malignant CSP tumors were 39.6 and 45.4 years of age, respectively. The stromal cellularity, stromal cellular atypism, high mitotic activity, atypic mitoses, stromal overgrowth, infiltrative tumor contour, and heterologous stromal elements were significant features of the malignant CSP tumors. Benign CSP tumors were predominantly of fibroadenomatous architecture with cellular stroma (mild or moderate) and some distortion and elongation of glandular elements. Five malignant CSP tumors were stained positively with p53, and 6 malignant CSP tumors were stained immunohistochemically with Ki-67. All benign CSP tumors were negatively stained for p53 and Ki-67. The patients with benign CSP tumors were treated with local excision ( n=11) and with subcutaneous mastectomy ( n=1). Malignant CSP tumors were treated with wide local excision ( n=1), partial mastectomy ( n=1), simple mastectomy ( n=2), and modified radical mastectomy ( n=5). Two patients with a high mitotic rate and high values of p53 and Ki-67 received additional radiotherapy and chemotherapy. One case had liver metastasis. This tumor had high mitotic figures, stromal overgrowth, severe stromal cellularity, and 20% Ki-67 and mild p53 positivity. We suggest that p53 and Ki-67 can play an important role in predicting prognosis and yielding additional therapy besides conventional prognostic factors in the treatment of the CSP patients.


Subject(s)
Biomarkers, Tumor/metabolism , Breast Neoplasms/metabolism , Ki-67 Antigen/metabolism , Phyllodes Tumor/metabolism , Tumor Suppressor Protein p53/metabolism , Adolescent , Adult , Aged , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Female , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Medical Records , Middle Aged , Phyllodes Tumor/secondary , Phyllodes Tumor/surgery , Prognosis , Radiography , Retrospective Studies , Turkey
19.
Turk J Gastroenterol ; 13(4): 236-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-16378314

ABSTRACT

Intussusception occurs rarely in adults. It presents with a variety of acute, intermittent, and chronic symptoms, thus making its preoperative diagnosis difficult. In adults, intussusceptions are mostly caused by organic lesions and the majority of these lesions are benign tumours. Computed tomography scanning and endoscopy have proved to be the most useful diagnostic methods. Confirmation of diagnosis and treatment of adult intussusception is surgical, with surgical resection of the intussusception without reduction being the preferred treatment in adults, as almost half of both colonic and enteric intussusceptions are associated with malignancy. We report the case of a patient with ileocolic intussusception due to an ileal lymphoma.

SELECTION OF CITATIONS
SEARCH DETAIL
...